Literature DB >> 30532851

Observation of short-term atorvastatin-induced changes in coronary arterial plaque properties using integrated backscatter intravascular ultrasound in a patient.

Koji Yamaguchi1, Tetsuzo Wakatsuki1, Toshiyuki Niki1, Yoshio Taketani1, Hiroyasu Oezuka2, Kenya Kusunose1, Takashi Iwase1, Hirotsugu Yamada1, Takeshi Soeki1, Masataka Sata1.   

Abstract

Integrated backscatter intravascular ultrasound (IB-IVUS) capable of assessing plaque properties has recently become clinically applicable. We observed short-term atorvastatin-induced changes in coronary arterial plaque properties using IB-IVUS. The patient was a 57-year-old man who underwent coronary angiography when admitted to our hospital for cerebrovascular surgery, and lesions were observed in 2 branches: 99% and 90% stenoses in the proximal anterior descending branch (LAD) and middle region of the circumflex, respectively. Stenting was performed for the LAD on November 4, 2009 and for the circumflex on December 9. Oral atorvastatin administration at 10 mg/day was initiated on November 5 because the LDL-cholesterol level was high (160 mg/dl). A region about 5 mm in length proximal to the stent placed in the LAD was analyzed using IB-IVUS. Atorvastatin lowered the LDL cholesterol level from 160 to 79 mg/dl. On IB image analysis, although the period was as short as about 1 month, a marked decrease in the fatty component (44% → 26%) and an increase in the fibrous component (53% → 66%) were observed in the plaque. It was suggested that atorvastatin changes the tissue properties of coronary arterial plaques from a very early phase. It might be associated with the stabilization of coronary plaque.

Entities:  

Keywords:  Atorvastatin; Early phase; IB-IVUS; Plaque stabilization

Year:  2011        PMID: 30532851      PMCID: PMC6265088          DOI: 10.1016/j.jccase.2011.03.007

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  7 in total

1.  Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin.

Authors:  T Takagi; K Yoshida; T Akasaka; T Hozumi; S Morioka; J Yoshikawa
Journal:  Am J Cardiol       Date:  1997-06-15       Impact factor: 2.778

2.  Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound.

Authors:  Masanori Kawasaki; Keiji Sano; Munenori Okubo; Haruko Yokoyama; Yoko Ito; Ichijiro Murata; Kunihiko Tsuchiya; Shinya Minatoguchi; Xiangrong Zhou; Hiroshi Fujita; Hisayoshi Fujiwara
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

3.  Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.

Authors:  M Schartl; W Bocksch; D H Koschyk; W Voelker; K R Karsch; J Kreuzer; D Hausmann; S Beckmann; M Gross
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

Review 4.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

5.  Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.

Authors:  Shinya Okazaki; Takayuki Yokoyama; Katsumi Miyauchi; Kazunori Shimada; Takeshi Kurata; Hitoshi Sato; Hiroyuki Daida
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study.

Authors:  Lisette Okkels Jensen; Per Thayssen; Knud Erik Pedersen; Steen Stender; Torben Haghfelt
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

7.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.